202 related articles for article (PubMed ID: 19125321)
1. Affective correlates of stimulant use and adherence to anti-retroviral therapy among HIV-positive methamphetamine users.
Carrico AW; Johnson MO; Colfax GN; Moskowitz JT
AIDS Behav; 2010 Aug; 14(4):769-77. PubMed ID: 19125321
[TBL] [Abstract][Full Text] [Related]
2. Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence.
Moore DJ; Blackstone K; Woods SP; Ellis RJ; Atkinson JH; Heaton RK; Grant I;
AIDS Care; 2012; 24(12):1504-13. PubMed ID: 22530794
[TBL] [Abstract][Full Text] [Related]
3. Methamphetamine use, sexual activity, patient-provider communication, and medication adherence among HIV-infected patients in care, San Francisco 2004-2006.
Marquez C; Mitchell SJ; Hare CB; John M; Klausner JD
AIDS Care; 2009 May; 21(5):575-82. PubMed ID: 19444665
[TBL] [Abstract][Full Text] [Related]
4. Aggregate versus day level association between methamphetamine use and HIV medication non-adherence among gay and bisexual men.
Parsons JT; Kowalczyk WJ; Botsko M; Tomassilli J; Golub SA
AIDS Behav; 2013 May; 17(4):1478-87. PubMed ID: 23553345
[TBL] [Abstract][Full Text] [Related]
5. Stimulant Use and Viral Suppression in the Era of Universal Antiretroviral Therapy.
Carrico AW; Hunt PW; Neilands TB; Dilworth SE; Martin JN; Deeks SG; Riley ED
J Acquir Immune Defic Syndr; 2019 Jan; 80(1):89-93. PubMed ID: 30272634
[TBL] [Abstract][Full Text] [Related]
6. Preintervention Profiles of Information, Motivational, and Behavioral Self-Efficacy for Methamphetamine Use and HIV Medication Adherence Among Gay and Bisexual Men.
Starks TJ; Millar BM; Lassiter JM; Parsons JT
AIDS Patient Care STDS; 2017 Feb; 31(2):78-86. PubMed ID: 28092450
[TBL] [Abstract][Full Text] [Related]
7. Stimulant use and HIV disease management among men in same-sex relationships.
Carrico AW; Woolf-King SE; Neilands TB; Dilworth SE; Johnson MO
Drug Alcohol Depend; 2014 Jun; 139():174-7. PubMed ID: 24726318
[TBL] [Abstract][Full Text] [Related]
8. Affect regulation, stimulant use, and viral load among HIV-positive persons on anti-retroviral therapy.
Carrico AW; Johnson MO; Moskowitz JT; Neilands TB; Morin SF; Charlebois ED; Steward WT; Remien RH; Wong FL; Rotheram-Borus MJ; Lightfoot MA; Chesney MA;
Psychosom Med; 2007 Nov; 69(8):785-92. PubMed ID: 17942835
[TBL] [Abstract][Full Text] [Related]
9. Stimulant use is associated with immune activation and depleted tryptophan among HIV-positive persons on anti-retroviral therapy.
Carrico AW; Johnson MO; Morin SF; Remien RH; Riley ED; Hecht FM; Fuchs D
Brain Behav Immun; 2008 Nov; 22(8):1257-62. PubMed ID: 18703133
[TBL] [Abstract][Full Text] [Related]
10. Perceived risks and amelioration of harm in research using mobile technology to support antiretroviral therapy adherence in the context of methamphetamine use: a focus group study among minorities living with HIV.
Pasipanodya EC; Kohli M; Fisher CB; Moore DJ; Curtis B
Harm Reduct J; 2020 Jun; 17(1):41. PubMed ID: 32527276
[TBL] [Abstract][Full Text] [Related]
11. Individualized texting for adherence building (iTAB) for methamphetamine users living with HIV: A pilot randomized clinical trial.
Moore DJ; Pasipanodya EC; Umlauf A; Rooney AS; Gouaux B; Depp CA; Atkinson JH; Montoya JL
Drug Alcohol Depend; 2018 Aug; 189():154-160. PubMed ID: 29958127
[TBL] [Abstract][Full Text] [Related]
12. Reasons for stimulant use among Latino gay men in San Francisco: a comparison between methamphetamine and cocaine users.
Díaz RM; Heckert AL; Sánchez J
J Urban Health; 2005 Mar; 82(1 Suppl 1):i71-8. PubMed ID: 15738318
[TBL] [Abstract][Full Text] [Related]
13. Internalized heterosexism among HIV-positive, gay-identified men: implications for HIV prevention and care.
Johnson MO; Carrico AW; Chesney MA; Morin SF
J Consult Clin Psychol; 2008 Oct; 76(5):829-39. PubMed ID: 18837600
[TBL] [Abstract][Full Text] [Related]
14. Methamphetamine Use Associated with Non-adherence to Antiretroviral Treatment in Men Who Have Sex with Men.
Lai HH; Kuo YC; Kuo CJ; Lai YJ; Chen M; Chen YT; Chen CC; Yen MY; Hu BS; Wang TH; Wang CC; Kuo LL; Yen TF; Chuang PH; Yen YF
Sci Rep; 2020 Apr; 10(1):7131. PubMed ID: 32346081
[TBL] [Abstract][Full Text] [Related]
15. The methamphetamine epidemic: implications for HIV prevention and treatment.
Colfax G; Shoptaw S
Curr HIV/AIDS Rep; 2005 Nov; 2(4):194-9. PubMed ID: 16343378
[TBL] [Abstract][Full Text] [Related]
16. Psychosocial Correlates of Monocyte Activation and HIV Persistence in Methamphetamine Users.
Grosgebauer K; Salinas J; Sharkey M; Roach M; Pallikkuth S; Dilworth SE; Pahwa S; Koru-Sengul T; Stevenson M; Carrico AW
J Neuroimmune Pharmacol; 2019 Mar; 14(1):16-22. PubMed ID: 30046962
[TBL] [Abstract][Full Text] [Related]
17. Amphetamine use and its associations with antiretroviral adherence and viral load among sexual minority men and transgender women living with HIV.
Brousseau NM; Kalichman SC; Watson RJ; Eaton LA
AIDS Care; 2023 Oct; 35(10):1472-1479. PubMed ID: 37139536
[TBL] [Abstract][Full Text] [Related]
18. Over the influence: The HIV care continuum among methamphetamine-using men who have sex with men.
Jin H; Ogunbajo A; Mimiaga MJ; Duncan DT; Boyer E; Chai P; Dilworth SE; Carrico AW
Drug Alcohol Depend; 2018 Nov; 192():125-128. PubMed ID: 30248558
[TBL] [Abstract][Full Text] [Related]
19. Mental health disorders and substance use among people living with HIV in Nepal: their influence on non-adherence to anti-retroviral therapy.
Pokhrel KN; Pokhrel KG; Sharma VD; Poudel KC; Neupane SR; Mlunde LB; Jimba M
AIDS Care; 2019 Aug; 31(8):923-931. PubMed ID: 30835503
[TBL] [Abstract][Full Text] [Related]
20. Psychological processes and stimulant use among men who have sex with men.
Carrico AW; Pollack LM; Stall RD; Shade SB; Neilands TB; Rice TM; Woods WJ; Moskowitz JT
Drug Alcohol Depend; 2012 Jun; 123(1-3):79-83. PubMed ID: 22088656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
